Literature DB >> 12227786

"Chiral perturbation factor" approach reveals importance of entropy term in stereocontrol of the 2,4-pentanediol-tethered reaction.

Takahiro Tei1, Yasuhiro Sato, Kazutake Hagiya, Akira Tai, Tadashi Okuyama, Takashi Sugimura.   

Abstract

The stereocontrol mechanism of the 2,4-pentanediol (PD)-tethered reaction was studied in detail using a reaction system consisting of phenyl and rhodium carbenoid moieties. Different tethers were examined to analyze the effects of the methyl groups on the PD tether. Among the reactions with these tethers, the PD tether achieves an unmeasurably high stereoselectivity in a diastereomeric ratio of >500. Another tether showing a high but measurable stereoselectivity in a ratio of 41 is mostly controlled by the entropy term. To clarify the role of the methyl groups on the chiral tethers, which are the origin of the stereocontrol, the "chiral perturbation factor" is introduced. This parameter is defined as the rate of a chiral reaction relative to that of an achiral reference reaction. By analyzing the temperature dependence of the chiral perturbation factors for different chiral-tethered reactions, high potentials of the PD-tethered reaction in its stereocontrol are concluded to be due to the entropy term.

Entities:  

Year:  2002        PMID: 12227786     DOI: 10.1021/jo025937s

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Modeling the antioxidant properties of the eye reduces the false-positive rate of a nonanimal eye irritation test (OptiSafe).

Authors:  Stewart J Lebrun; Sara Chavez; Roxanne Chan; Linda Nguyen; James V Jester
Journal:  Toxicol In Vitro       Date:  2021-06-30       Impact factor: 3.685

2.  In silico prediction of SARS protease inhibitors by virtual high throughput screening.

Authors:  Dariusz Plewczynski; Marcin Hoffmann; Marcin von Grotthuss; Krzysztof Ginalski; Leszek Rychewski
Journal:  Chem Biol Drug Des       Date:  2007-04       Impact factor: 2.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.